David Fox, P.C. - Partner

David Fox, P.C.

Download V-Card

New York
Phone: +1 212-446-4994
Fax: +1 212-446-4900

Kirkland Builds Leading M&A Practice On Big Hires, Deals
Kirkland's M&A practice is profiled. Kirkland, Wachtell Go 3 For 3 In Year's Biggest LBOs
Kirkland's recent M&A work is discussed. Key Lateral Hires Heading Kirkland Teams on Duff & Phelps, Zipcar Deals
Daniel Wolf is quoted regarding Kirkland's recent M&A deals. U.S. Innovative Lawyers Report
The Best Lawyers in America 2013
Local Firms Do Well in Deal Charts
David Fox discusses Kirkland’s recent M&A work. Bristol-Myers in Deal for Amylin Valued at $7 Billion
Kirkland represents Bristol-Myers Squibb Company in its agreement announced to acquire Amylin Pharmaceuticals for a total transaction value of approximately $7 billion. Kirkland & Ellis LLP Ranked a Top-Tier Firm by Chambers & Partners
Kirkland’s Deal Team Rises in First-Quarter M&A Rankings
Scott Falk, Jon Ballis and David Fox discuss Kirkland’s M&A Practice Group. Fast-Acting Duo: Dealmakers of the Year
David Fox and Jeffrey Symons are profiled as "Dealmakers of the Year" for their work for Teva Pharmaceuticals in its $6.8 billion acquisition of Cephalon. Dealmakers of the Year
Deal Diary: Feb. 6, 2012
Kirkland's M&A Practice Group has a "blockbuster" month in January 2012. Jones Day, Kirkland Advise on Eastman Chemical's $4.7 Billion Solutia Buy
Kirkland advises Solutia in its $4.7 billion acquisition by Eastman Chemical Company. Eastman Chemical to Buy Solutia for $3.4 Billion
Kirkland represents Solutia in its agreement to be acquired by Eastman Chemical Company for a total transaction value of about $4.7 billion. Kirkland, Dechert Advise as Bristol-Myers Squibb Acquires Inhibitex for $2.5 Billion
Kirkland advises Bristol-Myers Squibb in a $2.5 billion acquisition deal with Inhibitex, Inc. M&A Group Of The Year: Kirkland & Ellis
Kirkland is named as one of the five "M&A Groups of the Year." The Top of the Class in Deal-Making
Kirkland advised on several of the top deals in 2011, according to the New York Times Dealbook blog. The article highlights work for clients Koor Industries, Bain Capital, Exco Resources, Fundtech, Avis Budget Group, iGate and Teva Pharmaceuticals. Small Change, Big Difference
David Fox is quoted in this article about Kirkland's "standout" ranking for 3G and "highly commended" ranking for Avis in the FT's 2011 Innovative Lawyers Report. U.S. Innovative Lawyers Report
Teva Ordered to Sell Rights to Three Generics
Kirkland represents Teva Pharmaceuticals in its purchase of Cephalon Inc. Kirkland Aids Tronox-Exxaro Mining Assets Deal
Kirkland represents Tronox Incorporated in its acquisition of the mineral sands operations of Exxaro Resources Limited. The team is mentioned. The Best Lawyers in America 2012
The Transatlantic Elite
Avis Budget to Buy Avis Europe for $1 Billion
Kirkland represents Avis Budget Group in its acquisition of Avis Europe. The Deal Tacticians
Kirkland's M&A practice is discussed in this article profiling David Fox, Daniel Wolf, Stephen Fraidin, Stephen Oetgen, William Sorabella, George Stamas, Jeffrey Symons and James Sprayregen are mentioned. Recent antitrust hires Tim Muris, Christine Wilson, Bilal Sayyed and Ian Conner are also mentioned. Dealmakers of the Week: David Fox and Jeffrey Symons of Kirkland & Ellis
David Fox and Jeffrey Symons are profiled for their work for Teva Pharmaceuticals. Teva Outbids Valeant in $6.8 Billion Deal for Cephalon
Kirkland represented Teva in its deal to acquire Cephalon. Kirkland & Ellis LLP Represents Koor Industries in $2.4 Billion Agreement with ChemChina
So Where Does Dollar Thrifty Go From Here?
Kirkland's work for Avis in its bid for Dollar Thrifty is discussed. Dollar Thrifty Shareholders Reject Hertz Bid
Kirkland represents Avis in their bid for Dollar Thrifty. Bristol to Acquire ZymoGenetics for $885 Million
Kirkland represented Bristol-Myers Squibb Co. in its acquisition of ZymoGenetics Inc in a deal valued at $885 million. The Best Lawyers in America 2011
Kirkland & Ellis Advises Teva in Acquisition of Ratiopharm
Rental Car Wars: Five Firms On Hand As Avis Tries Harder for Dollar Thrifty
David Fox and Daniel Wolf represented Avis in its $1.3 billion offer for Dollar Thrifty Automotive Group. Kirkland, Brown Winick on $1 Billion Herbicide Deal
David Fox represented Makhteshim in the acquisition of herbicide supplier Albaugh Inc. for about $1 billion. Dinner and a Q&A with the Pay Master
Kirkland hosted a dinner and lively debate in New York with clients and Kenneth Feinberg, special master for executive compensation at the U.S. Department of Treasury. David Fox is quoted. Kirkland's Skadden Hires Pay Dividends
A year after joining Kirkland & Ellis, David Fox and Daniel Wolf's contributions to the Firm are discussed. Kirkland, Freshfields Lead on $5 Billion Pharma Deal
David Fox and Volker Kullmann led Teva Pharmaceutical Industries in an EUR3.625 billion acquisition of German generics producer Ratiopharm. Teva Beats Pfizer to Win Ratiopharm for $5 Billion
David Fox and Volker Kullmann led Teva Pharmaceutical Industries in an EUR3.625 billion acquisition of German generics producer Ratiopharm. Solutia to Purchase Solar-Supplies Firm
Kirkland advised Solutia in its $326 million acquisition of Etimex Solar. Laterals of the Year
Starring Roles: Laterals of the Year
In the 12 months ending in September 30, 2009, 2,775 partners left or joined the biggest firms in the country. Dale Cendali and David Fox are profiled as two of 20 high-profile attorneys who made the move last year. Tyco to buy Brink's Home Security
David Fox and Jeffrey Symons advised Citigroup in their representation of Tyco International in an acquisition of Brinks Home Security. The Peculiarities of Tender Offers
David Fox and Daniel Wolf are mentioned with regard to a recent Kirkland alert that discusses tender offers. The Best Lawyers in America 2010
David Fox and Daniel Wolf Join Kirkland & Ellis to Expand Mergers & Acquisition Practice
In Sign of Industry Shift, a Legal Giant Loses 2 Top Partners
David Fox and Daniel Wolf have joined the New York office as partners in the Corporate Practice Group. Kirkland & Ellis Adds a Fox And a Wolf to Its New York Office
David Fox and Daniel Wolf have joined the New York office as partners in the Corporate Practice Group. New partner Mark Filip and returning partner Jeff Rosen are also mentioned.